Position
Chief Executive Officer
Company
Akari Therapeutics
Description
Akari Therapeutics Plc announced the appointment of Abizer Gaslightwala as President and Chief Executive Officer (CEO), effective April 21, 2025. He brings 25 years of experience in the biotechnology and pharmaceutical industry, having most recently served as the Senior Vice President and Franchise Head for US Oncology at Jazz Pharmaceuticals.
Quick answer
Akari Therapeutics Plc Appoints Abizer Gaslightwala as President and CEO (March 20, 2025). Akari Therapeutics is based in Tampa, Florida, United States.
- Who is the new Chief Executive Officer at Akari Therapeutics?
- Akari Therapeutics named Abizer Gaslightwala Chief Executive Officer, announced March 20, 2025.
- What did Akari Therapeutics announce on March 20, 2025?
- Akari Therapeutics Plc announced the appointment of Abizer Gaslightwala as President and Chief Executive Officer (CEO), effective April 21, 2025. He brings 25 years of experience in the biotechnology and pharmaceutical industry, having most recently served as the Senior Vice President and Franchise Head for US Oncology at Jazz Pharmaceuticals.
- What does Akari Therapeutics do?
- Akari Therapeutics is an oncology biotech company developing novel antibody drug conjugates (ADCs) with its first payload, PH1, a spliceosome modulator that disrupts RNA splicing in cancer cells.
- Where is Akari Therapeutics based?
- Akari Therapeutics is based in Tampa, Florida, United States.
- Which similar companies made leadership changes around the same time?
- Cantargia AB (April 1, 2025), Algorae Pharmaceuticals (April 3, 2025), Wugen (February 26, 2025) and Climb Bio, Inc. (February 25, 2025) also announced leadership changes within 45 days of Akari Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in research and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Cantargia Appoints Morten Lind Jensen as Chief Medical Officer (April 1, 2025)
- Algorae Pharmaceuticals Appoints Vishal Shah as Chief Commercial Officer (April 3, 2025)
- Wugen, Inc. Appoints Jim Faulkner as Chief Technology Officer (February 26, 2025)
- Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer (February 25, 2025)
- Manas AI Appoints Jonathan Baell as Chief Scientific Officer (April 17, 2025)
- AAVantgarde Appoints Rasmus Holm-Jorgensen as Chief Financial Officer (April 28, 2025)
Who to call at Akari Therapeutics, and when
A new leader at Akari Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Akari Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Akari Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Akari Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Akari Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Akari Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.